Skip To Main Content
Barbara Melosky on Muck Rack

Barbara Melosky

As seen in: Wiley Online Library, Memory Studies, MDPI, Future Medicine, OncLive, Lung Cancer, TechTrends
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara

Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer

|
By Barbara Melosky, Natasha Leighl, Normand Blais, David Dawe
| MDPI
Open AccessGuidelines by Barbara L. Melosky 1,*, Natasha B. Leighl 2, David Dawe 3, Normand Blais 4, Paul F. Wheatley-Price 5, Quincy S.-C. Chu 6, Rosalyn A. Juergens 7, Peter M. Ellis 8, Alexander Sun 9,10, Devin Schellenberg 11, Diana N. Ionescu 12,13 and Parneet K.
Open in Who Shared Issue with article?

Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non‐small cell lung cancer

|
By Barbara Melosky, Mark Vincent, Anna L McGuire, Anthony Brade
| Wiley Online Library Verified
1 INTRODUCTION Lung cancer is the leading cause of cancer-related mortality, with over 2.2 million new cases diagnosed and nearly 1.8 million deaths in 2020.1 Non-small cell lung cancer (NSCLC) accounts for close to 85% of cases2 and approximately 20%–30% of patients present with early-stage disease with the potential for curative-intent surgical resection or definitive radiotherapy.3-7 The concept of cure is integral to the management of NSCLC as it shapes diagnosis, prognosis, treatment...
Open in Who Shared Issue with article?

Current Oncology | Free Full-Text | Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study

|
By Stephen Yip, Barbara Melosky, Cheryl Ho, Roy Avraham Hilzenrat
| MDPI
Open AccessArticle by Roy Avraham Hilzenrat 1, Stephen Yip 2, Barbara Melosky 3, Cheryl Ho 3, Janessa Laskin 3, Sophie Sun 3, James J. Choi 1 and Anna L.
Open in Who Shared Issue with article?
See all 13 licensed articles (15 Total)